Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SARS-CoV-2 Virus Antigen (SARS-CoV-2 Antigen)
- Target
- SARS-CoV-2 Antigen
- Molecular classification
- Glycoprotein, Phosphoprotein
01
Overview
SARS-CoV-2 virus antigens, primarily the Spike (S) glycoprotein and Nucleocapsid (N) phosphoprotein, are viral proteins recognized by the host immune system. The S protein mediates viral entry via ACE2 receptor binding and is the main target for neutralizing antibodies and vaccines. The N protein packages the viral RNA and is useful in diagnostics. Both elicit strong antibody responses, but only S protein antibodies confer direct neutralization.
- Other names
- SARS-CoV-2 Spike (S) glycoproteinSARS-CoV-2 Nucleocapsid (N) phosphoproteinS proteinN protein
02
Mechanism of action
Neutralization of viral entry (Spike antibodies), Induction of adaptive immunity (Spike vaccines)
03
Biological functions
Viral entryImmune recognitionRNA packagingStabilization of viral RNA genome
04
Disease associations
COVID-19Infection
05
Safety considerations
Antibody-dependent enhancement (ADE)Efficacy against variantsPotential for immune evasion
06
Interacting drugs
Monoclonal antibodies (targeting Spike)
1 more in the full profile.
07
Biomarkers
Anti-Spike antibody titersAnti-RBD antibody titersAnti-Nucleocapsid antibody titers
Beyond the preview
Go deeper on SARS-CoV-2 Virus Antigen (SARS-CoV-2 Antigen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SARS-CoV-2 Virus Antigen (SARS-CoV-2 Antigen).